Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Jul 31
Love0

EXTRA, EXTRA, Treatment Approaches for EXTRAmammary Paget Disease

By Chuck Lin No Comments
INTRODUCTIONExtramammary Paget Disease (EMPD) is a rare intraepithelial malignancy of pluripotent keratinocyte stem cells that presents on apocrine-rich skin of the perineum, vulva, and less commonly, axilla.1 EMPD clinically presents…
Read More
Jul 31
Love0

No Racial Differences Found in Access to Biologics: A Population-Based Study of Psoriasis Patients in the United States

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic inflammatory disease that affects more than 7.5 million people in the United States.1 Although psoriasis is most prevalent in whites (3.2%), African Americans often exhibit more…
Read More
Jul 31
Love0

Off-Label Use of Baricitinib in Dermatology

By Chuck Lin No Comments
INTRODUCTIONBaricitinib is a reversible Janus kinase (JAK) 1 and 2 inhibitor approved for use in the European Union and the United States for various dermatological conditions. In the US, current…
Read More
Jul 25
Love0

Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis: Week 28 Interim Analysis of a Phase 4 Study

By Chuck Lin No Comments
INTRODUCTIONPlaque psoriasis is a chronic, inflammatory skin disorder spanning a patient's lifetime and hence requires long-term management.1 Psoriasis is a multisystem disease that remarkably impacts patients' physical health and is…
Read More
Jul 25
Love0

A Review of Tapinarof: Novel Topical Treatment for Plaque Psoriasis in Adults

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic, immune-mediated, multisystem, inflammatory dermatological condition that is persistent and relapsing.1 It affects 3.2% of the American adult population and an estimated 125 million people worldwide. The…
Read More
Jul 25
Love0

Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis

By Chuck Lin No Comments
INTRODUCTIONTopical corticosteroids (TCS) continue to be a mainstay of primary and/or adjunctive therapy for all severities of psoriasis. Corticosteroid-containing topical medications include both monotherapy and combination formulations with vitamin D…
Read More
Jul 25
Love0

Diagnosis and Management of Pediatric Psoriasis: An Overview for Pediatricians

By Chuck Lin No Comments
INTRODUCTIONPsoriasis (PsO) is a chronic, inflammatory skin disease characterized by cutaneous features, extracutaneous comorbidities, and an unpredictable course.1,2 PsO is the second most common chronic pediatric skin disorder after atopic…
Read More
Jul 22
Love0

INDIVIDUAL ARTICLE: Fixed Combination Calcipotriene/Betamethasone (Cal/BDP) Cream: Evaluating the Role of Polyaphron Dispersion (PAD) Technology in Psoriasis Treatment

By Chuck Lin No Comments
INTRODUCTIONPsoriasis vulgaris is a chronic, immune-mediated skin disease originating from a combination of environmental and genetic factors. Approximately 80% of psoriasis patients exhibit mild-to-moderate disease, for which topical therapies remain…
Read More
Jul 22
Love0

INDIVIDUAL ARTICLE: An Algorithm for the Management of Atopic Dermatitis in People With Skin of Color

By Chuck Lin No Comments
INTRODUCTIONVariations in the epidemiology, clinical presentation, disease course, and impact on quality of life have been reported in SOC populations.1 Epidemiologic studies focused on atopic dermatitis (AD) suggest a higher…
Read More
Jul 20
Love0

Review of Superficial Cryotherapy for the Treatment of Alopecia Areata

By Chuck Lin No Comments
INTRODUCTIONAlopecia areata (AA) is an autoimmune hair loss disorder arising due to loss of hair follicle immune privilege.1 Increased antigen presentation at the bulb of the hair follicle leads to…
Read More
Jul 10
Love0

Tapinarof, a Novel, First-in-Class, Topical Therapeutic Aryl Hydrocarbon Receptor Agonist for the Management of Psoriasis

By Chuck Lin No Comments
INTRODUCTIONCurrent Treatments and Unmet Needs in Psoriasis Psoriasis is a chronic, immune-mediated skin disease that affects approximately 8 million adults in the Unite States and 2% to 3% of people…
Read More
Jul 10
Love0

Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review

By Chuck Lin No Comments
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic, oftentimes debilitating inflammatory skin condition characterized by abscesses, inflammatory nodules, sinus tracts, and scarring.1 Existing data suggest multifactorial etiology with genetic, hormonal, and immune…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Alopecia Areata in Skin of Color: Trichoscopic Analysis in Black/African American Patients July 21, 2025
  • Photoprotection Efficacy of Sun Protection Factor and Iron Oxide Formulations in Diverse Skin With Melasma and Photodamage July 20, 2025
  • Probiotics Supplementation Improves Quality of Life, Clinical Symptoms, and Inflammatory Status in Patients With Psoriasis July 19, 2025
  • Broad-Spectrum & Visible Light Photoprotection Strategies for Diverse Patients – from Basic Science to Product Innovation July 18, 2025
  • One Size Doesn’t Fit All: Rethinking Atopic Dermatitis Through a Broader Lens July 17, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |      ADVERTISING POLICY

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search